Moreover, in triple negative breast cancer, the mesenchymal subtype showed the highest expression level of TRPC1, while the basal subtype with lymph-node metastasis was associated with high TRPC1 expression and worse prognosis [47]. Here, TRPC1 is linked to triple-negative breast carcinoma.